Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan.

MLA

Lee, Yoo-Young, et al. “Impact of Adjuvant Treatment on Survival in Patients with 2023 FIGO Stage IIC Endometrial Cancer: A Retrospective Analysis from Two Tertiary Centers in Korea and Taiwan.” Journal of Gynecologic Oncology, vol. 35, no. 3, May 2024, p. e33. EBSCOhost, https://doi.org/10.3802/jgo.2024.35.e33.

APA

Lee, Y.-Y., Lai, Y.-L., Kim, M.-S., Chang, K., Kim, H.-S., Cheng, W.-F., & Chen, Y.-L. (2024). Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan. Journal of Gynecologic Oncology, 35(3), e33. https://doi.org/10.3802/jgo.2024.35.e33

Chicago

Lee, Yoo-Young, Yen-Ling Lai, Myeong-Seon Kim, Koping Chang, Hyun-Soo Kim, Wen-Fang Cheng, and Yu-Li Chen. 2024. “Impact of Adjuvant Treatment on Survival in Patients with 2023 FIGO Stage IIC Endometrial Cancer: A Retrospective Analysis from Two Tertiary Centers in Korea and Taiwan.” Journal of Gynecologic Oncology 35 (3): e33. doi:10.3802/jgo.2024.35.e33.